Lisa C. McClain· SellGSK
Oct 31, 2025 · $1,001 to $15,000
Receipt-backed STOCK Act disclosure
As of August 5 at 6:38 PM EDT
Sell · Oct 16, 2023
Tommy Tuberville sold GSK.
GSK. This page identifies a public filing and does not imply motive, causation, or wrongdoing.
Amount range
$1,001 to $15,000
Owner
Joint
Filed
Nov 16, 2023
Filing delay
31 days · within the 45-day window
Receipt
Official filing 25e0814a-7ea9-41b7-96e6-9c59fbc8c0e3
Same-window market context
Comparable GSK and SPY closes are not available on identical dates for this transaction window.
Related activity
Receipt-qualified trades in the same tickers by other congressional filers.
Lisa C. McClain· BuyGSK
Oct 30, 2025 · $1,001 to $15,000
Lisa C. McClain· SellGSK
Oct 30, 2025 · $1,001 to $15,000
Valerie Hoyle· SellGSK
Sep 23, 2025 · $1,001 to $15,000
Lisa Mcclain· BuyGSK
Aug 4, 2025 · $1,001 to $15,000
Robert B. Aderholt· SellGSK
Jul 28, 2025 · $1,001 to $15,000
Get the weekly congress trading digest
One source-linked summary each week. Confirm by email; unsubscribe anytime.
Official receipt
This official filing is available from its primary-source link.
This source does not provide an embeddable PDF. Open the official filing in a new tab.